Bio-Connect
Mouse lymph node lysates probed with CD8 Polyclonal Antibody, unconjugated (bs-0648R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody at 1:10000 for 60 minutes at 37°C.
Mouse lymph node lysates probed with CD8 Polyclonal Antibody, unconjugated (bs-0648R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody at 1:10000 for 60 minutes at 37°C.
Mouse lymph node lysates probed with CD8 Polyclonal Antibody, unconjugated (bs-0648R) at 1:300 overnight at 4°C followed by a conjugated secondary antibody at 1:10000 for 60 minutes at 37°C.

CD8 Polyclonal Antibody

BS-0648R
Bioss
ApplicationsFlow Cytometry
Product group Antibodies
ReactivityHuman, Mouse
TargetCd8a
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bioss
  • Product Name
    CD8 Polyclonal Antibody
  • Delivery Days Customer
    16
  • Applications
    Flow Cytometry
  • Applications Supplier
    Flow-Cyt(1:50)
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 ug/ul
  • Conjugate
    Unconjugated
  • Gene ID12525
  • Target name
    Cd8a
  • Target description
    CD8 subunit alpha
  • Target synonyms
    Ly-2, Ly-35, Ly-B, Lyt-2, T-cell surface glycoprotein CD8 alpha chain, CD8 antigen, alpha chain, Lyt-2.1 lymphocyte differentiation antigen (AA at 100), T-cell surface glycoprotein Lyt-2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP01731
  • Protein Name
    T-cell surface glycoprotein CD8 alpha chain
  • Reactivity
    Human, Mouse
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Zhang Y, Wang Y, Shao L, et al. Knockout of beta-2 microglobulin reduces stem cell-induced immune rejection and enhances ischaemic hindlimb repair via exosome/miR-24/Bim pathway. J Cell Mol Med. 2020,24(1):695-710. doi: 10.1111/jcmm.14778
    Read this paper
  • Yuan SJ, Xu YH, Wang C, et al. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer. J Nanobiotechnology. 2019,17(1):110. doi: 10.1186/s12951-019-0541-8
    Read this paper
  • Demontoux L, Derangère V, Pilot T, et al. Hypotonic stress enhances colon cancer cell death induced by platinum derivatives and immunologically improves antitumor efficacy of intraperitoneal chemotherapy. Int J Cancer. 2019,145(11):3101-3111. doi: 10.1002/ijc.32590
    Read this paper
  • Wan WJ, Qu CX, Zhou YJ, et al. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy. Int J Pharm. 2019,566:731-744. doi: 10.1016/j.ijpharm.2019.06.030
    Read this paper
  • Sun J, Zhao G. Clinical effects of lentinan combined with budesonide inhalation in treating acute exacerbation of chronic obstructive pulmonary disease under mechanical ventilation. Exp Ther Med. 2019,17(3):1503-1508. doi: 10.3892/etm.2019.7149
    Read this paper
  • Zhang H, Jia E, Xia W, et al. Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune response. Vaccine. 2019,37(15):2090-2098. doi: 10.1016/j.vaccine.2019.02.055
    Read this paper
  • Mödinger Y, Rapp AE, Vikman A, et al. Reduced Terminal Complement Complex Formation in Mice Manifests in Low Bone Mass and Impaired Fracture Healing. Am J Pathol. 2019,189(1):147-161. doi: 10.1016/j.ajpath.2018.09.011
    Read this paper
  • Li TF, Li K, Zhang Q, et al. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma. Biomaterials. 2018,181:35-52. doi: 10.1016/j.biomaterials.2018.07.035
    Read this paper
  • Wang Y, Sun J, Zhang K, et al. Black tea and D. candidum extracts play estrogenic activity via estrogen receptor α-dependent signaling pathway. Am J Transl Res. 2018,10(1):114-125.
    Read this paper
  • Zhu M, Ding X, Zhao R, et al. Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma. J Control Release. 2018,272:72-82. doi: 10.1016/j.jconrel.2018.01.004
    Read this paper